Matches in SemOpenAlex for { <https://semopenalex.org/work/W4375865422> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4375865422 abstract "Background Switching therapies is common for patients with psoriasis.Objective To quantify real-world switching rates and characteristics among patients initiating biologics over 24 months.Methods Patients aged ≥18 years with ≥2 confirmed psoriasis diagnoses who initiated a new biologic were identified from a US-payer claims database (Merative® MarketScan®) Switching rates were reported over 24 months using Kaplan–Meier survival analysis, and multivariable Cox regression analyses were performed to identify associated patient characteristics.Results A total of 7997 patients were included, with overall treatment switch rates at 14.4% at 12 months and 26.0% at 24 months. IL-23 inhibitors were associated with the lowest risk of switching compared with TNF, IL-17, and IL-12/23 inhibitors over 24 months (p < 0.0001). Switch rates varied between specific biologics, with the lowest switch rates observed for patients treated with risankizumab at 8.5% followed by guselkumab at 15.7% over 24 months. Prior targeted immune modulator use, age, and female gender were predictors of switching (adjusted hazard ratio; 1.23, 1.31, and 1.40, respectively; p ≤ 0.0005).Limitations Claims data may be subject to data errors and reasons for switching cannot be determined.Conclusion Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors." @default.
- W4375865422 created "2023-05-10" @default.
- W4375865422 creator A5003753200 @default.
- W4375865422 creator A5006777927 @default.
- W4375865422 creator A5033903141 @default.
- W4375865422 creator A5043326530 @default.
- W4375865422 creator A5069063369 @default.
- W4375865422 creator A5089250111 @default.
- W4375865422 date "2023-05-16" @default.
- W4375865422 modified "2023-09-29" @default.
- W4375865422 title "Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States" @default.
- W4375865422 cites W1508752722 @default.
- W4375865422 cites W2003425690 @default.
- W4375865422 cites W2030348118 @default.
- W4375865422 cites W2063627867 @default.
- W4375865422 cites W2091442391 @default.
- W4375865422 cites W2099687194 @default.
- W4375865422 cites W2100023645 @default.
- W4375865422 cites W2116956799 @default.
- W4375865422 cites W2117064660 @default.
- W4375865422 cites W2276035339 @default.
- W4375865422 cites W2289328021 @default.
- W4375865422 cites W2322390243 @default.
- W4375865422 cites W2326421238 @default.
- W4375865422 cites W2328415131 @default.
- W4375865422 cites W2558385573 @default.
- W4375865422 cites W2570140560 @default.
- W4375865422 cites W2586118822 @default.
- W4375865422 cites W2797132528 @default.
- W4375865422 cites W2887412253 @default.
- W4375865422 cites W2912058252 @default.
- W4375865422 cites W3007389533 @default.
- W4375865422 cites W3028355101 @default.
- W4375865422 cites W3041951930 @default.
- W4375865422 cites W3156099989 @default.
- W4375865422 cites W3173226927 @default.
- W4375865422 cites W3211379308 @default.
- W4375865422 cites W4213058992 @default.
- W4375865422 cites W4285493691 @default.
- W4375865422 doi "https://doi.org/10.1080/09546634.2023.2200870" @default.
- W4375865422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37154473" @default.
- W4375865422 hasPublicationYear "2023" @default.
- W4375865422 type Work @default.
- W4375865422 citedByCount "2" @default.
- W4375865422 countsByYear W43758654222023 @default.
- W4375865422 crossrefType "journal-article" @default.
- W4375865422 hasAuthorship W4375865422A5003753200 @default.
- W4375865422 hasAuthorship W4375865422A5006777927 @default.
- W4375865422 hasAuthorship W4375865422A5033903141 @default.
- W4375865422 hasAuthorship W4375865422A5043326530 @default.
- W4375865422 hasAuthorship W4375865422A5069063369 @default.
- W4375865422 hasAuthorship W4375865422A5089250111 @default.
- W4375865422 hasBestOaLocation W43758654221 @default.
- W4375865422 hasConcept C126322002 @default.
- W4375865422 hasConcept C16005928 @default.
- W4375865422 hasConcept C207103383 @default.
- W4375865422 hasConcept C2780564577 @default.
- W4375865422 hasConcept C44249647 @default.
- W4375865422 hasConcept C50382708 @default.
- W4375865422 hasConcept C71924100 @default.
- W4375865422 hasConceptScore W4375865422C126322002 @default.
- W4375865422 hasConceptScore W4375865422C16005928 @default.
- W4375865422 hasConceptScore W4375865422C207103383 @default.
- W4375865422 hasConceptScore W4375865422C2780564577 @default.
- W4375865422 hasConceptScore W4375865422C44249647 @default.
- W4375865422 hasConceptScore W4375865422C50382708 @default.
- W4375865422 hasConceptScore W4375865422C71924100 @default.
- W4375865422 hasIssue "1" @default.
- W4375865422 hasLocation W43758654221 @default.
- W4375865422 hasLocation W43758654222 @default.
- W4375865422 hasLocation W43758654223 @default.
- W4375865422 hasOpenAccess W4375865422 @default.
- W4375865422 hasPrimaryLocation W43758654221 @default.
- W4375865422 hasRelatedWork W1601575360 @default.
- W4375865422 hasRelatedWork W1988093201 @default.
- W4375865422 hasRelatedWork W2530478834 @default.
- W4375865422 hasRelatedWork W2600617605 @default.
- W4375865422 hasRelatedWork W2971521915 @default.
- W4375865422 hasRelatedWork W2982536114 @default.
- W4375865422 hasRelatedWork W2994686985 @default.
- W4375865422 hasRelatedWork W3016935296 @default.
- W4375865422 hasRelatedWork W3035875330 @default.
- W4375865422 hasRelatedWork W3089170113 @default.
- W4375865422 hasVolume "34" @default.
- W4375865422 isParatext "false" @default.
- W4375865422 isRetracted "false" @default.
- W4375865422 workType "article" @default.